# Inadequate Gonadal Replacement in Patients with Turner Syndrome may Result in Pituitary Volume Enlargement

## TL;DR

Inadequate hormone therapy in Turner syndrome patients may enlarge the pituitary gland and raise FSH levels.

## Contribution

This study shows that low-dose estrogen therapy in Turner syndrome patients is linked to pituitary enlargement and higher FSH levels.

## Key findings

- Patients on low-dose conjugated estrogen had larger pituitary volumes (0.58±0.15 cm³) compared to others (0.40±0.17 cm³).
- Low-dose estrogen patients had higher serum FSH levels than those on combination therapy (p=0.001).

## Abstract

Patients with Turner syndrome need hormone replacement therapy for puberty induction. However, it is not known whether inadequate hormone replacement therapy affects the pituitary.

Patients with Turner syndrome (n=35) and healthy control (n=20) (age/gender matched) subjects were included. MRI imaging of the pituitary was used to calculate pituitary volumes. According to the estradiol regimen, patients were divided into two groups; (i) those treated with low-dose conjugated oestrogen (CE, 0.625 mg) and (ii) those treated with combination therapy (ethinyl estradiol+sipropterone acetate; 35 mcg/2 mg). Pituitary measurements were calculated according to pituitary borders and their distances to each other via pituitary MRI.

Pituitary hyperplasia (0.58±0.15 cm3
vs. 0.40±0.17 cm3) was determined in patients with low dose conjugated estrogen compared to the other patients or healthy control subjects (0.42±0.16 cm3) (p=0.005). Serum FSH levels of the patients treated with low dose CE were also higher compared to the patients who received combination therapy (p=0.001).

Inadequate hormone replacement therapy can cause devastating effects on the bones and uterine health and disrupts the pituitary structure.